Bone Biologics Corp (BBLG)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $1.10M
Last updated: Nov 17, 2026 at 11:03 AM ET
Bone Biologics Corp (BBLG) Competitors
The companies most similar to Bone Biologics are BioRestorative Therapies (BRTX), Silexion Therapeutics (SLXN) and HCW Biologics (HCWB). By market cap, Bone Biologics ranks 10th of the 13 companies on this page; FibroBiologics, Inc. Common Stock (FBLG) is the largest at $6.57M.
Peer Comparison
BBLG's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Bone Biologics (BBLG) | $1.10M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| BioRestorative Therapies Inc (BRTX) | $2.06M | N/A | 70.3x | 0.0% | -289.9% | -7.3% | 0.00% |
| Silexion Therapeutics Corp (SLXN) | $1.29M | N/A | 5.9x | 0.0% | N/A | 0.0% | 0.00% |
| HCW Biologics Inc (HCWB) | $1.73M | N/A | 0.2x | -83.1% | -51.6% | 1970.0% | 0.00% |
| Matinas BioPharma Holdings Inc (MTNB) | $881570 | 0.9x | N/A | 0.0% | -187.9% | -100.0% | 0.00% |
| Revelation Biosciences Inc (REVB) | $2.43M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Purple Biotech (PPBT) | $2.65M | N/A | N/A | 0.0% | -156.2% | 0.0% | 0.00% |
| Virax Biolabs Group Limited Ordinary Shares (VRAX) | $823940 | N/A | 14.3x | 0.0% | N/A | 685.0% | 0.00% |
| Calidi Biotherapeutics Inc. (CLDI) | $2.29M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Genprex Inc (GNPX) | $1.71M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| GeoVax Labs Inc (GOVX) | $928290 | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| VivoSim Labs, Inc. (VIVS) | $2.58M | N/A | 15.1x | 0.0% | N/A | -51.4% | 0.00% |
| FibroBiologics, Inc. Common Stock (FBLG) | $6.57M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $1.89M | 0.9x | 14.3x | 0.0% | -172.0% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Bone Biologics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| BioRestorative Therapies Inc (BRTX) | BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue... | BRTX competitors |
| Silexion Therapeutics Corp (SLXN) | Biomotion Sciences (SLXN) is a forward-thinking biotechnology firm specializing in regenerative medicine... | SLXN competitors |
| HCW Biologics Inc (HCWB) | HCW Biologics Inc is a forward-thinking biotechnology company focused on pioneering immunotherapies and vaccine technologies to tackle pressing health issues... | HCWB competitors |
| Matinas BioPharma Holdings Inc (MTNB) | Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery and development of several candidate products. | MTNB competitors |
| Revelation Biosciences Inc (REVB) | Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of immunological diagnostics and therapeutics... | REVB competitors |
| Purple Biotech (PPBT) | Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs in the United... | PPBT competitors |
| Virax Biolabs Group Limited Ordinary Shares (VRAX) | Virax Biolabs Group Limited, a biotechnology company, sells, distributes and markets diagnostic test kits and medical technology products and PPE... | |
| Calidi Biotherapeutics Inc. (CLDI) | Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer. | CLDI competitors |
| Genprex Inc (GNPX) | Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. | GNPX competitors |
| GeoVax Labs Inc (GOVX) | GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using a modified... | GOVX competitors |
| VivoSim Labs, Inc. (VIVS) | VivoSim Labs, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. | VIVS competitors |
| FibroBiologics, Inc. Common Stock (FBLG) | FibroBiologics, Inc. is an innovative biotechnology company dedicated to advancing regenerative medicine through its proprietary fibroblast cell technology... | FBLG competitors |
Frequently Asked Questions About BBLG
Who are Bone Biologics' main competitors?
The companies most similar to Bone Biologics include BioRestorative Therapies (BRTX), Silexion Therapeutics (SLXN), HCW Biologics (HCWB), Matinas BioPharma Holdings (MTNB) and Revelation Biosciences (REVB), listed from the closest match.
Who is Bone Biologics' biggest competitor?
FibroBiologics, Inc. Common Stock (FBLG) is the largest of the similar companies at $6.57M; BioRestorative Therapies (BRTX) is the closest match by business profile, size, sector and industry.
How does BBLG stock compare with its competitors?
BBLG's net margin is 0.0% against a peer median of 0.0%.
Which of Bone Biologics' competitors pays a higher dividend?
Bone Biologics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Bone Biologics bigger than its competitors?
No. Bone Biologics is 10th by market cap among the 13 companies on this page; the largest is FibroBiologics, Inc. Common Stock (FBLG) at $6.57M.
BBLG pages: Overview, Earnings, Forecast, Financials, Competitors